Exor N.V. has closed today the agreement to acquire a 10% shareholding of Institut Mérieux, the privately held global healthcare holding of the Mérieux family. A consideration of €278 million, corresponding to one third of the €833 million total investment, was paid today by way of a reserved capital increase, while the remaining amount is expected to be contributed within the next 12 months.
As part of the partnership sealed with the Mérieux family, John Elkann and Benoît Ribadeau-Dumas have joined Institut Mérieux’s Board of Directors.
Files
